June 4, 2022
The University of Cincinnati's Thomas Herzog, MD, is presenting a poster describing a new immunotherapy trial for platinum-resistant ovarian cancer, called ARTISTRY-7, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
December 5, 2022
University of Cincinnati researchers have published a new study examining factors behind the decision to begin or decline medication treatment for childhood anxiety disorders after cognitive behavioral therapy did not lead to improvement.
April 14, 2023
The University of Cincinnati Cancer Center's Melinda Butsch Kovacic and colleagues will present research abstracts on several community outreach and engagement initiatives at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19.
March 29, 2023
University of Cincinnati research on the steroid dexamethasone's effect on immune cells and benefit to severe COVID-19 patients was recently published in Frontiers in Immunology.
October 20, 2022
New research out of the University of Cincinnati shows that a course of a hepatitis B vaccine provides complete protection for people with HIV. The UC research shows that a three-dose course of the hepatitis B vaccine HEPLISAV-B provides complete protection for people living with HIV who have never been vaccinated against or exposed to the hepatitis B virus (HBV).
October 13, 2022
The University of Cincinnati's Jeffrey Strawn, MD, is senior author of a new editorial in JAMA discussing new recommendations that children and adolescents ages 8 to 18 should be screened for anxiety disorders.
October 23, 2023
The American Cancer Society has awarded the University of Cincinnati Cancer Center a $360,000 Institutional Research Grant that will provide pilot grant support for early-stage investigators working in cancer-related fields.
August 24, 2022
Radiology Business highlighted the research of the University of Cincinnati's Prashanth Ravi and Frank Rybicki that found an in-house 3D print shop saved almost $3,000 per patient in operating-room costs thanks to shortened procedure times.
December 7, 2022
Psychiatry Advisor highlighted recent University of Cincinnati research that found in utero exposure to certain flame retardant chemicals may be a risk factor for developing anxiety symptoms in early adolescence.
December 6, 2022
Forbes highlighted research from the University of Cincinnati's Jeffrey Mills and Jeffrey Strawn examining factors behind the decision to begin or decline medication treatment for childhood anxiety disorders after cognitive behavioral therapy did not lead to improvement.